# Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

> **NCT00828269** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **PROCEDURE:** Comparator: Fine needle aspiration biopsy

## Key facts

- **NCT ID:** NCT00828269
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828269, "Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00828269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*